Insights

Fraud Alert

It has come to our attention that certain individuals are posing as recruiters from our company and engaging in fraudulent activities. We, at CACTUS, would like to alert all our stakeholders and potential job applicants about these deceptive practices.

Kindly note the following:

All authorized recruiters from CACTUS use official email addresses ending with @cactusglobal.com or @talent.icims.eu. Please do not entertain job offers or communication from anyone using different domain names.
Our company never requests any payment or fees from candidates at any stage of the recruitment process. If you encounter any such request, please consider it fraudulent and report it to your local authorities.
CACTUS bears no responsibility for any financial transactions conducted outside our official channels. Please exercise caution and verify all job-related communications through our official channels only.

We value the trust of our stakeholders and are committed to maintaining the integrity of our recruitment process. If you have any questions or require further clarification, please do not hesitate to contact us at ta@cactusglobal.com.

Thank you for your attention and cooperation in helping us combat fraudulent activities.

Please refrain from sending your CV or any other enquiries to this email address as this account is solely dedicated to the monitoring of fraudulent activities.

EXPLORE INSIGHTS

.

Unlocking the Power of Global Capability Centers (GCCs) in Biopharma: Drive Efficiency, Innovation, and Scientific Excellence

Top Stories

What’s Next for Global Capability Centers )?

MAPS 2025 Decoded: The Medical Affairs Playbook

Medical Affairs 2.0: GenAI as the Catalyst for

Filter

Which Regulatory Requirements Are Applicable to “Legacy” Devices?

Simple Considerations before Determining S&P Objectives for Medical Devices

Effectiveness of Artificial Intelligence-Powered Translation Tools in Developing Medical Publications: An Assessment of Japanese-to-English Translation

Racial and Ethnic Diversity in Pharma and Clinical Trials

The Business Case for Diversity, Equity, and Inclusion (DE&I) in the Pharma Industry

Promoting Diversity and Inclusion in Clinical Trials – New England Journal of Medicine’s New Policy

Learn more ABOUT our company.

Fraud Alert